Are there times during cancer treatment when I shouldn’t have sex?

 

Ask a Question

Q: Are there times during cancer treatment when I shouldn’t have sex? 

A: Yes. In the days and weeks after surgery, your health care professional may recommend that you abstain from sex to prevent irritating the incision or pulling out stitches. Also, if you’re undergoing treatment that makes you susceptible to infection, your doctor may want you to avoid contact with anyone, especially intimate contact.

When you’re able to have sex, it’s very important that you practice safe sex, using protection against physical contact with all sexual partners. That’s because people who’ve been diagnosed with cancer, or are in treatment, are more likely to have weakened immune systems. This increases your vulnerability to infections of all types.

While you’re having chemotherapy, use barrier contraceptives, such as condoms. Chemotherapy drugs may be excreted in body fluids and unintentionally enter your partner’s body. You also want to prevent pregnancy at this time because treatment exposes the fetus to dangers from chemotherapy drugs in early pregnancy.
--Bernice Crook, RN, OCN

Learn how chemotherapy can affect your sex life. 

Latest Cancer News
Avastin® Linked with Increased Risk of Blood Clots

November 20, 2008 — According to a combined analysis of previously published studies, cancer patients who use Avastin® (bevacizumab) may have an increased risk of venous thromboembolism (a blood clot in a vein). These results were published in the Journal of the American Medical Association.

Addition of Avastin® to Paraplatin®, Taxol®, and Erbitux® Promising for Advanced NSCLC

November 20, 2008 — Researchers affiliated with the Southwest Oncology Group have reported that the four-drug combination of chemotherapy agents Paraplatin® (carboplatin) and Taxol® (paclitaxel) plus targeted therapies Avastin® (bevacizumab) and Erbitux® (cetuximab) is safe and may improve survival in patients with advanced non–small cell lung cancer (NSCLC). The details of this study were presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology November 13-15.

Avastin® Increases Risk of Venous Thromboembolism

November 20, 2008 — Researchers from Stony Brook University have reported that the use of Avastin® (bevacizumab) increases the risk of thromboembolism. The details of this review were published in the November 19, 2008 issue of the Journal of the American Medical Association.

Select news items provided by Reuters Health